Publication Name	World Journal of Diabetes
Manuscript ID	4959
Country	Brazil

Received	2013-08-14 08:43
Peer-Review Started	2013-08-15 10:19
To Make the First Decision	2013-08-21 18:44
Return for Revision	2013-08-29 17:31
Revised	2013-10-21 02:33
Second Decision	2014-01-16 14:25
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-01-16 14:41
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-02-15 16:55
Publish the Manuscript Online	2014-02-19 15:19

ISSN	1948-9358 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Autobiography
Article Title	Starting glargine in insulin-naïve type 2 diabetic patients based on body mass index is safe
Manuscript Source	Invited Manuscript
All Author List	Denise R Franco, Juliana Baptista, Fatima RM Abreu, Risoneide B Batista and Freddy G Eliaschewitz
Funding Agency and Grant Number	Funding Agency Grant Number Sanofi-Aventis Brazil
Corresponding Author	Denise R Franco, MD, Medical Department, Clinical Research Center (CPCLIN), Rua Goias 193, São Paulo 01244-030, Brazil. d9franco@terra.com.br
Key Words	Type 2 diabetes; Insulin glargine; Basal insulin; Hypoglycemia; Titration algorithms
Core Tip	To start insulin therapy in insulin na?ve type 2 diabetes patients, a long-acting basal insulin, such as insulin glargine, is added once a day. The majority of algorithms determine insulin titration according to fasting plasma glucose levels, but the dosage differs at the initial dose, frequency and speed of adjustments. It is difficult to compare the different algorithms employed in trials with populations of different socio-economic strata and variable access to educational materials. Here, we compared the safety of different titration algorithms in a population that was homogeneous in terms of socio-economic strata and with the same degree of education in diabetes.
Publish Date	2014-02-19 15:19
Citation	Franco DR, Baptista J, Abreu FRM, Batista RB, Eliaschewitz FG. Starting glargine in insulin-na?ve type 2 diabetic patients based on body mass index is safe. World J Diabetes 2014; 5(1): 69-75 Available from: URL: http://www.wjgnet.com/1948-9358/ full/v5/i1/69.htm DOI: http://dx.doi.org/10.4239/wjd.v5.i1.69
URL	http://www.wjgnet.com/1948-9358/full/v5/i1/69.htm
DOI	http://dx.doi.org/10.4239/wjd.v5.i1.69

Full Article (PDF)	WJD-5-69.pdf
Full Article (Word)	WJD-5-69.doc
Manuscript File	4959-Review.doc
Answering Reviewers	4959-Answering reviewers.pdf
Copyright License Agreement	4959-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	4959-Language certificate.pdf
Peer-review Report	4959-Peer reviews.pdf
Scientific Editor Work List	4959-Scientific editor work list.doc